GOSS
Gossamer Bio Inc
11,90$
+8,9 %
zum Vortag
≈ 10,40 € (umgerechnet) · Stand: 18.09.2026
Schlusskurs · Stand: 17. Sep 2026
Investor Relations
Berichtstermine
Investor-Relations-Überblick zu Gossamer Bio Inc (GOSS): Berichtstermine, Gewinn-Überraschungen, Earnings-Call-Mitschriften und aktuelle Meldungen. Der nächste Bericht ist für den 04.11.2026 angesetzt.
Nächster Bericht
04.11.2026
Letzter Bericht
13.08.2026
EPS-Schätzung geschlagen
Gesamte Historie
9 von 32 Quartalen (28 %)
Letzte 16 Quartale
8 von 16 Quartalen (50 %)
Earnings-Call-Mitschriften
- 18.05.2026 Earnings Call Q1 2026 Englisches Original Öffnen →
Nachrichten zur Aktie
- 16.09.2026 Gossamer Bio, Inc. (GOSS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 11.09.2026 Gossamer Bio, Inc. (GOSS): Material Modifications to Rights of Security Holders; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Other Events; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 09.09.2026 Gossamer Bio, Inc. (GOSS): Other Events; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 03.09.2026 Gossamer Bio, Inc. (GOSS): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 26.08.2026 Gossamer Bio, Inc. (GOSS): Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 21.08.2026 Gossamer Bio, Inc. (GOSS): Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 13.08.2026 Gossamer Bio, Inc. (GOSS): Results of Operations and Financial Condition; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 27.07.2026 Gossamer Bio, Inc. (GOSS): Entry into a Material Definitive Agreement; Termination of a Material Definitive Agreement; Results of Operations and Financial Condition; Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Öffnen ↗
- 15.07.2026 Gossamer Bio, Inc. (GOSS): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders; Financial Statements and Exhibits · sec.gov Öffnen ↗
Automatisch zugeordnete Agentur- und Portalmeldungen; externe Links öffnen die Originalquelle.
Datenstand: 17. September 2026 · Quelle: Fundamentaldaten & SEC-Berichte (Geschäfts- und Quartalsberichte, 10-K/10-Q) · Mitschriften: Transkript-Archiv
Hinweis: reine Faktenanalyse, keine Anlageberatung und keine Aufforderung zum Kauf oder Verkauf. Angaben ohne Gewähr.